NCT06453980 Multimodal Investigation of Neural Plasticity
| NCT ID | NCT06453980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Mild Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-05-13 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-05-13 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in cognitively intact older adults (healthy controls, HC) and in those with mild cognitive impairment (MCI).
Eligibility Criteria
Inclusion Criteria: * Normal cognition for HC and diagnosis of Mild Cognitive Impairment (MCI) for MCI participants * Right-handedness * Magnetic resonance compatible, criteria that also apply for high definition transcranial direct current stimulation (HD-tDCS; e.g., absence of metallic or electronic implants in the upper body or head) Exclusion Criteria: * History of other contributing neurological or medical conditions known to affect cognitive functioning * Significant mental illness * Sensory impairments that limit ability to participate * History of alcohol or drug abuse/dependence
Contact & Investigator
Alexandru Iordan, PhD
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT06453980 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06453980 currently recruiting?
Yes, NCT06453980 is actively recruiting participants. Contact the research team at hariniba@umich.edu for enrollment information.
Where is the NCT06453980 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT06453980 clinical trial?
NCT06453980 is sponsored by University of Michigan. The principal investigator is Alexandru Iordan, PhD at University of Michigan. The trial plans to enroll 80 participants.